Recent insights into the pathogenesis of pre-eclampsia

Placenta

Volumn 23, Issue 5, 2002, Pages 359-372

  Roberts, J M ^a   Lain, K Y ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE PREDISPOSITION; ECTOPIC PREGNANCY; ENDOTHELIUM; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PLACENTA PERFUSION; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TROPHOBLAST; ADAPTATION; ADULT; BLOOD FLOW; FEMALE; FETOMATERNAL TRANSFUSION; FETUS HYPOXIA; PATHOLOGY; PLACENTA; PREGNANCY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADAPTATION, PHYSIOLOGICAL; ADULT; DISEASE SUSCEPTIBILITY; ENDOTHELIUM, VASCULAR; FEMALE; FETAL HYPOXIA; HUMANS; MATERNAL-FETAL EXCHANGE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REGIONAL BLOOD FLOW;

EID: 0036579918     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2002.0819     Document Type: Review

References (233)

1. Abi-Said D, Annegers JF, Combs-Cantrell D, Frankowski RF & Willmore LJ (1995) Case-control study of the risk factors for eclampsia. Am J Epidemiol, 142, 437-441.
2. Abitbol M, Piriani F, Ober W, Drisoll S & Cohen M (1976) Production of experimental toxemia in the pregnant dog. Obstet Gynecol, 48, 577-548.
3. Adam B, Malatyalioglu E, Alvur M, Kokcu A & Bedir A (1998) Plasma atrial natriuretic peptide levels in preeclampsia and eclampsia. Journal of Maternal-Fetal Investigation, 8, 85-88.
4. Allaire AD, Ballenger KA, Wells SR, McMahon MJ & Lessey BA (2000) Placental apoptosis in preeclampsia. Obstet Gynecol, 96, 271-276.
5. Anim-Nyame N, Sooranna SR, Steer PJ & Johnson MR (2000) Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod, 15, 2033-2036.
6. Arias F, Rodriquez L, Rayne SC & Kraus FT (1993) Maternal placental vasculopathy and infection: Two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol, 168, 585-591.
7. Arngrimsson R, Bjornsson H & Geirsson RT (1995) Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome. Hypertension in Pregnancy, 14, 27-38.
8. Ashworth JR, Warren AY, Baker PN & Johnson DM (1996) A comparison of endothelium-dependent relaxation in omental and myometrial resistance arteries in pregnant and nonpregnant women. Am J Obstet Gynecol, 175, 1307-1312.
9. Assali NS & Prystowsky H (1950) Studies on autonomie blockade. I. Comparison between the effects of tetraethylammonium chloride (TEAC, and high selective spinal anesthesia on blood pressure of normal and toxemic pregnancy. J Clin Invest, 29, 1354.
10. Baker PN, Davidge ST, Barankiewicz J & Roberts JM (1996) Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension, 27, 56-61.
11. Baker PN, Davidge ST & Roberts JM (1995) Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension, 26, 244-248.
12. Bass KE, Morrish D, Roth I, Bhardwaj D, Taylor R, Zhou Y & Fisher S (1994) Human cytotrophoblast invasion is up-regulated by epidermal growth factor: evidence that paracrine factors modify this process. Dev Biol, 164, 1-12.
13. Benyo DF, Miles TM & Conrad KP (1997) Hypoxia stimulates cytokine production by villous explants from the human placenta. Journal of Clinical Endocrinology & Metabolism, 82, 1582-1588.
14. Boffa MC, Valsecchi L, Fausto A, Gozin D, Dangelo SV, Safa O, Castiglioni MT, Amiral J & Dangelo A (1998) Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Thromb Haemost, 79, 1092-1095.
15. Bosio PM, McKenna PJ, Conroy R & O'Herlihy C (1999) Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstetrics & Gynecology, 94, 978-984.
16. Branch DW, Dudley DJ, LaMarche S & Mitchell MD (1992) Sera from preeclamptic patients contain factor(s) that stimulate prostacyclin production by human endothelial cells. Prostaglandins Leukot Essent Fatty Acids, 45, 191-195.
17. Branch DW, Mitchell MD, Miller E, Palinski W & Witztum JL (1994) Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet, 343, 645-646.
18. Brosens IA, Robertson WB & Dixon HG (1979) The role of the spiral arteries in the pathogenesis of preeclampsia. In Obstetrics and Gynecology Annual (Ed.) Wynn R, pp. 177-191.
19. Brown MA, Wang JA & Whitworth JA (1997) The renin-angiotensin- aldosterone system in pre-eclampsia. Clin Exp Hypertens, 19, 713-726.
20. Bussen SS, Sutterlin MW & Steck T (1998) Plasma renin activity and aldosterone serum concentration are decreased in severe preeclampsia but not in the HELLP-Syndrome. Acta Obstet Gynecol Scand, 77, 609-613.
21. Calvert SM, Tuffnell DJ & Haley J (1996) Poor predictive value of platelet count, mean platelet volume and serum urate in hypertension in pregnancy. European Journal of Obstetrics, Gynecology and Reproductive Biology, 64, 179-184.
22. Calvin S, Corrigan J, Weinstein L & Jeter M (1988) Factor VIII: von Willebrand factor patterns in the plasma of patients with pre-eclampsia. Am J Perinatol, 5, 29-32.
23. Campbell DM & Campbell AJ (1983) Evans blue disappearance rate in normal and pre-eclamptic pregnancy. Clinical and Experimental Hypertension. Part B. Hypertension In Pregnancy, 2, 163-169.
24. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M & Lye SJ (1999) Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest, 103, 1641-1650.
25. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M & Post M (2000) Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest, 105, 577-587.
26. Cargnoni A, Gregorini G, Ceconi C, Maiorca R & Ferrari R (1994) Lipid peroxidation in normal pregnancy and preeclampsia. Adv Exp Med Biol, 366, 420-421.
27. Cavanagh D, Rao P, Tsai C & O Connor T (1977) Experimental toxemia in the pregnant primate. Am J Obstet Gynecol, 128, 75-85.
28. Cester N, Staffolani R, Rabini RA, Magnanelli R, Salvolini E, Galassi R, Mazzanti L & Romanini C (1994) Pregnancy induced hypertension: a role for peroxidation in microvillus plasma membranes. Mol Cell Biochem, 131, 151-155.
29. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, Shennan AH, Steer PJ & Poston L (1999) Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet, 354, 810-816.
30. Chesley LC (1966) Vascular reactivity in normal and toxemic pregnancy. Clin Obstet Gynecol, 9, 871-881.
31. Chesley LC (1978) Hypertensive Disorders of Pregnancy. New York: Appleton-Century-Crofts.
32. Chesley LC, Annitto JE & Cosgrove RA (1976) The remote prognosis of eclamptic women: Sixth periodic report. Am J Obstet Gynecol, 124, 446-459.
33. Cockell AP, Learmont JG, Smarason AK, Redman CWG, Sargent IL & Poston L (1997) Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. British Journal of Obstetrics and Gynaecology, 104, 235-240.
34. Cockell AP & Poston L (1997) Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension, 30, 247-251.
35. Combs CA, Katz MA, Kitzmiller JL & Brescia RJ (1993) Experimental preeclampsia produced by chronic constriction of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys. Am J Obstet Gynecol, 169, 215-223.
36. Conrad KP & Benyo DF (1997) Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol, 37, 240-249.
37. Conrad KP, Miles TM & Benyo DF (1998) Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol, 40, 102-111.
38. Coonrod DV, Hickok DE, Zhu K, Easterling TR & Dating JR (1995) Risk factors for preeclampsia in twin pregnancies: a population-based cohort study. Obstet Gynecol, 85, 645-650.
39. Craven CM, Morgan T & Ward K (1998) Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta, 19, 241-252.
40. Cross JC, Werb Z & Fisher SJ (1994) Implantation and the placenta: key pieces of the development puzzle. [Review]. Science, 266, 1508-1518.
41. Damsky CH, Fitzgerald ML & Fisher SJ (1992) Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest, 89, 210-222.
42. Daniel Y, Kupferminc MJ, Baram A, Jaffa AJ, Fait G, Wolman I & Lessing JB (1998) Plasma interleukin-12 is elevated in patients with preeclampsia. Am J Reprod Immunol, 39, 376-380.
43. Davidge ST, Baker PN & Roberts JM (1995) NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am J Physiol, 269, H1106-H1112.
44. Davidge ST, Signorella AP, Hubel CA, Lykins DL & Roberts JM (1996a) Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin. Hypertension, 28, 758-764.
45. Davidge ST, Signorella AP, Lykins DL, Gilmour CH & Roberts JM (1996b) Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women. Am J Obstet Gynecol, 175, 1301-1306.
46. deGroot CJM & Taylor RN (1993) New insights into the etiology of pre-eclampsia. Ann Med, 25, 243-249.
47. deGroot CJM, Merrill DC, Taylor RN, Kitzmiller JL, Goldsmith PC & Roberts JM (1997) Increased von Willebrand factor expression in an experimental model of preeclampsia produced by reduction of utero-placental perfusion pressure in conscious rhesus monkeys. Hypertension in Pregnancy, 16, 177-185.
48. deGroot DJM, Davidge ST, Friedman SA, McLaughlin MK, Roberts JM & Taylor RN (1995) Plasma from preeclamptic women increases human endothelial cell prostacyclin production without changes in enzyme activity or mass. Am J Obstet Gynecol, 172, 976-985.
49. Dekker GA (1994) Etiology and pathophysiology of preeclampsia. Zentralbl Gynakol, 116, 57-60.
50. Dekker GA, Devries JIP, Doelitzsch PM, Huijgens PC, Vonblomberg BME, Jakobs C & Vangeijn HP (1995) Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol, 173, 1042-1048.
51. Demoerloose P, Mermillod N, Amiral J & Reber G (1998) Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum - comparison with tissue-type plasminogen activator and plasminogen aActivator inhibitor-1. Thromb Haemost, 79, 554-556.
52. DeWolff, Robertson WB & Brosens I (1975) The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol, 123, 164-173.
53. DiFederico E, Genbacev O & Fisher SJ (1999) Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol, 155, 293-301.
54. Dizon-Townson DS, Nelson LM, Easton K & Ward K (1996) The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol, 175, 902-905.
55. Easterling TR (1992) The maternal hemodynamics of preeclampsia. Clin Obstet Gynecol, 35, 375-385.
56. Efiong E (1975) Pregnancy in the overweight Nigerian. Br J Obstet Gynaecol, 82, 903-906.
57. Ekholm EMK, Tahvanainen KUO & Metsala T (1997) Heart rate and blood pressure variabilities are increased in pregnancy-induced hypertension. Am J Obstet Gynecol, 177, 1208-1212.
58. Endresen MJR, Morris JM, Nobrega AC, Buckley D, Linton EA & Redman CWG (1998) Serum from preeclamptic women induces vascular cell adhesion molecule-1 expression on human endothelial cells in vitro-a possible role of increased circulating levels of free fatty acids. Am J Obstet Gynecol, 179, 665-670.
59. Eneroth E, Remberger M, Vahlne A & Ringden O (1998) Increased serum concentrations of interleukin-2 receptor in the first trimester in women who later developed severe preeclampsia. Acta Obstet Gynecol Scand, 77, 591-593.
60. Eskenazi B, Fenster L & Sidney S (1991) A multivariate analysis of risk factors for preeclampsia. Journal of the American Medical Association, 266, 237-241.
61. Eskenazi B, Fenster L, Sidney S & Elkin EP (1993) Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol, 169, 1112-1118.
62. Ferris TF (1991) Pregnancy, preeclampsia, and the endothelial cell. New England Journal of Medicine, 325, 1439-1440.
63. Fisher KA, Luger A, Spargo BH & Lindheimer MD (1981) Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis. Medicine, 60, 267-276.
64. Fisher S, Cui T, Zhang L, Hartman L, Grahl K, Zhang G, Tarpey J & Damsky CH (1989) Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. The Journal of Cell Biology International, 109, 891-902.
65. Fisher S, Genbacev O, Maidji E & Pereira L (2000) Human cytomegalovirus infection of placental cytotrophoblasts In vitro and In utero: implications for transmission and pathogenesis [In Process Citation]. J Virol, 74, 6808-6820.
66. Fitzgerald DJ, Entman SS, Mulloy K & Fitzgerald GA (1987) Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation, 75, 956-963.
67. Fitzgerald DJ & Fitzgerald GA (1990) Eiconsanoids in the pathogenesis of preeclampsia. In Hypertension: Pathophysiology Diagnosis, and Management (Eds) Laragh J & Brenner B, pp. 1789-1805. New York, NY: Raven Press Ltd.
68. Friedman SA, deGroot CJM, Taylor RN, Heilbron DC & Roberts JM (1994) Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol, 170, 838-841.
69. Friedman SA, Schiff E, Emeis JJ, Dekker GA & Sibai BM (1995) Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol, 172, 202-203.
70. Friedman SA, Taylor RN & Roberts JM (1991) Pathophysiology of preeclampsia. Clin Perinatol, 18, 661-682.
71. Furugori K, Kurauchi O, Itakura A, Kanou Y, Murata Y, Mizutani S, Seo H, Tomoda Y & Nakamura T (1997) Levels of hepatocyte growth factor and its messenger ribonucleic acid in uncomplicated pregnancies and those complicated by preeclampsia. J Clin Endocrinol Metab, 82, 2726-2730.
72. Gaber LW, Spargo BH & Lindheimer MD (1994) Renal pathology in pre-eclampsia. [Review] [68 refs]. Baillieres Clinical Obstetrics & Gynaecology, 8, 443-468.
73. Gallery EDM, Saunders DM, Boyce ES & Györy AZ (1980) Relation between plasma volume and uric acid in the development of hypertension in pregnancy. Baltimore: University Park Press, pp. 175-189.
74. Gant M, Daley G, Chand S, Whalley P & Macdonald P (1973) A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest, 52, 2682-2689.
75. Garzetti GG, Tranquilli AL, Cugini AM, Mazzanti L, Cester N & Romanini C (1993) Altered lipid composition, increased lipid peroxidation, and altered fluidity of the membrane as evidence of platelet damage in preeclampsia. Obstet Gynecol, 81, 337-340.
76. Geary M, Pringle PJ, Persaud M, Wilshin J, Hindmarsh PC, Rodeck CH & Brook CG (1999) Leptin concentrations in maternal serum and cord blood: relationship to maternal anthropometry and fetal growth [see comments]. British Journal of Obstetrics & Gynaecology, 106, 1054-1060.
77. Genbacev O, Joslin R, Damsky CH, Polliotti BM & Fisher SJ (1996) Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest, 97, 540-550.
78. Genbacev O, Zhou Y, Ludlow JW & Fisher SJ (1997) Regulation of human placental development by oxygen tension. Science, 277, 1669-1672.
79. Gilmour CA, Patrick TE & Roberts JM (1998) Increased umbilical cellular fibronectin concentrations are associated with a decreased prevalence of growth restriction in preeclampsia. Journal of the Society for Gynecologic Investigation (submitted).
80. Glueck CJ, Kupfermine MJ, Fontaine RN, Wang P, Weksler BB & Eldor A (2001) Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol, 97, 44-48.
81. Goldenberg RL & Rouse DJ (1998) Prevention of premature birth. N Engl J Med, 339, 313-320.
82. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, Montanaro S, Pavone G & Di Minno G (1997) Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost, 77, 1052-1054.
83. Gray PH, Ocallaghan MJ, Mohay HA, Burns YR & King JF (1998) Maternal hypertension and neurodevelopmental outcome in very preterm infants. Arch Dis Child, 79, F88-F93.
84. Greenwood JP, Stoker JB, Walker JJ & Mary D (1998) Sympathetic nerve discharge in normal pregnancy and pregnancy-induced hypertension. J Hypertens, 16, 617-624.
85. Greer IA, Lyall F, Perera T, Boswell F & Macara LM (1994) Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol, 84, 937-940.
86. Haig D (1993) Genetic conflicts in human pregnancy. The Quarterly Review of Biology, 68, 495-519.
87. Hamilton M, Varner M & Ward K (1996). A common mutation which causes hyperhomocysteinemia is not associated with pregnancy induced hypertension. In ISSHP 10th World Conference, pp. 96.
88. Higgins JR, Papayianni A, Brady HR, Darling MRN & Walshe JJ (1998) Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy-evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia. Am J Obstet Gynecol, 179, 464-469.
89. Highman TJ, Friedman JE, Huston LP, Wong WW & Catalano PM (1998) Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol, 178, 1010-1015.
90. Hodgkinson C, Hodare A & Bumpus F (1967) Experimental hypertensive disease of pregnancy. Obstet Gynecol, 30, 371-380.
91. Hsu CD, Copel JA, Hong S-F & Chan DW (1995) Thrombomodulin levels in preeclampsia, gestational hypertension, and chronic hypertension. Obstet Gynecol, 86, 897-899.
92. Hubel C & Roberts J (1999) Lipid metabolism and oxidative stress. In Chesley's Hypertensive Disorders in Pregnancy (Ed.) Lindheimer M, Roberts J & Cunningham F, pp. 453-486. Appleton & Lange.
93. Hubel CA (1997) Oxidative stress and preeclampsia. Fetal and Maternal Medicine Review, 9, 73-101.
94. Hubel CA, Gandley RE, Shakir Y, Gallaher M & Roberts JM (1997) Prevalence of small low-density lipoproteins is increased in preeclampsia. J Soc Gynecol Invest, 4, 95A (Abstract).
95. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ & Roberts JM (1996) Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol, 174, 975-982.
96. Hubel CA, Roberts JM & Ferrell RE (1999) Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene. Clin Genet, 56, 289-296.
97. Hubel CA, Snaedal S, Ness RB, Weissfeld LA, Geirsson RT, Roberts JM & Arngrimsson R (2000) Dyslipoproteinaemia in postmenopausal women with a history of eclampsia. Br J Obstet Gynaecol, 107, 776-784.
98. Huppertz B, Frank HG, Reister F, Kingdom J, Korr H & Kaufmann P (1999) Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab Invest, 79, 1687-1702.
99. Hutt R, Ogunniyi SO, Sullivan HF & Elder MG (1994) Increased platelet volume and aggregation precede the onset of preeclampsia. Obstet Gynecol, 83, 146-149.
100. Irwin DE, Savitz DA, Hertz-Picciotto I & Andre KAS (1994) The risk of pregnancy-induced hypertension: black and white differences in a military population. Am J Public Health, 84, 1508-1510.
101. Ishitobi F, Sagiya A, Ueda Y, Oka K, Kanaya H & Iidaka K (1991) Morphometric analysis of the glomerular capillary area-a comparison of minimal change nephrotic syndrome, focal glomerular sclerosis, and preeclampsia. Journal of Pathology, 165, 329-336.
102. Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Sibai BM & Catalano PM (1998a) The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Am J Obstet Gynecol, 179, 1032-1037.
103. Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Sibai BM & Catalano PM (1998b) The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol, 179, 1032-1037.
104. Kaaja R, Tikkanen M, Viinikka L & Ylikorkala O (1995) Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol, 85, 353-356.
105. Khaliq A, Dunk C, Jiang J, Shams M, Li XF, Acevedo C, Weich H, Whittle M & Ahmed A (1999) Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for 'placental hyperoxia' in intrauterine growth restriction. Lab Invest, 79, 151-170.
106. Khan KS, Hashmi FA & Rizvi JH (1995) Are non-diabetic women with abnormal glucose screening test at increased risk of pre-eclampsia, macrosomia and Caesarian birth? JPMA-Journal of the Pakistan Medical Association, 45, 176-179.
107. Khong TY (1991) Acute atherosis in pregnancies complicated by hypertension, small-for-gestational-age infants, and diabetes mellitus. Arch Pathol Lab Med, 115, 722-725.
108. Khong TY, De Wolf F, Robertson WB & Brosens I (1986) Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol, 93, 1049-1059.
109. Khong TY & Mott C (1993) Immunohistologic demonstration of endothelial disruption in acute atherosis in pre-eclampsia. European Journal of Obstetrics, Gynecology, & Reproductive Biology, 51, 193-197.
110. Khong TY, Pearce JM & Robertson WB (1987) Acute atherosis in preeclampsia: Maternal determinants and fetal outcome in the presence of the lesion. Am J Obstet Gynecol, 157, 360-363.
111. Kincaid-Smith P (1991) The renal lesion of preeclampsia revisited. Am J Kidney Dis, 17, 144-148.
112. Kitzmiller J & Benirschki K (1973) Immunoflourescent studies of placental bed vessels in pre-eclampsia. Am J Obstet Gynecol, 115, 248-251.
113. Klonoff-Cohen HS, Savitz DA, Cefalo RC & McCann MF (1989) An epidemiologic study of contraception and preeclampsia [see comments]. Journal of the American Medical Association, 262, 3143-3147.
114. Knight M, Redman CWG, Linton EA & Sargent IL (1998) Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol, 105, 632-640.
115. Knock GA & Poston L (1996) Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol, 175, 1668-1674.
116. Knuist M, Bonsel GJ, Zondervan HA & Treffers PE (1998) Riskfactors for preeclampsia in nulliparous women in distinct ethnic Groups-a prospective cohort study. Obstet Gynecol, 92, 174-178.
117. Kobashi G (1995) A case-control study of pregnancy-induced hypertension with a genetic predisposition: association of a molecular variant of angiotensinogen in the Japanese women. Hokkaido Igaku Zasshi-Hokkaido Journal of Medical Science, 70, 649-657.
118. Kraayenbrink AA, Dekker GA, van Kamp GJ & van Geijn HP (1993) Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol, 169, 160-165.
119. Kuban KCK, Leviton A, Pagano M, Fenton T, Strassfeld R & Wolff M (1992) Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol, 7, 70-76.
120. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A & Lessing JB (2000) Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol, 96, 45-49.
121. Kupferminc MJ, Peaceman AM, Aderka D, Wallach D & Socol ML (1996) Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol, 88, 420-427.
122. Kyle PM, Buckley RN, Kissane J, de Swiet M & Redman CWG (1995) The angiotensin sensitivity test and low-dose aspirin are ineffective methods to predict and prevent hypertensive disorders in nulliparous pregnancy. Am J Obstet Gynecol, 173, 865-872.
123. Laivuori H, Kaaja R, Koistinen H, Karonen SL, Andersson S, Koivisto V & Ylikorkala O (2000) Leptin during and after preeclamptic or normal pregnancy: Its relation to serum insulin and insulin sensitivity. Metabolism-Clinical and Experimental, 49, 259-263.
124. Levy R, Smith SD, Chandler K, Sadovsky Y & Nelson DM (2000) Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. American Journal of Physiology-Cell Physiology, 278, C982-C988.
125. Librach CL, Feigenbaum SL, Bass KE, Cui T-Y, Verastas N, Sadovsky Y, Quigley JP, French DL & Fisher SJ (1994) Interleukin-1B regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. The Journal of Biological Chemistry, 269, 7125-7131.
126. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH & Fisher SJ (1991) 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. The Journal of Cell Biology International, 113, 437-449.
127. Lockwood C & Peters J (1990) Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol, 162, 358-362.
128. Lyall F, Barber A, Myatt L, Bulmer J & Robson S (2000) Hemeoxygenase expression in human placenta and placental bed implies a role in regulation of trophoblast invasion and placental function. FASEB J, 14, 208-219.
129. Lyall F, Bulmer J, Kelly H, Duffie E & Robson S (1999) Human trophoblast invasion and spiral artery transformation: the role of nitric oxide. Am J Pathol, 154, 1105-1114.
130. Malee MP, Malee KM, Azuma SD, Taylor RN & Roberts JM (1992) Increases in plasma atrial natriuretic peptide concentration antedate clinical evidence of preeclampsia. Journal of Clinical Endocrinology Metabolism, 74, 1095-1100.
131. Many A, Hubel CA, Fisher SJ, Roberts JM & Zhou Y (2000) Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol, 156, 321-331.
132. Martin D & Conrad KP (2000) Expression of endothelial nitric oxide synthase by extravillous trophoblast cells in the human placenta. Placenta, 21,23-31.
133. Martin D, Gonzalez JL, Gardner MO, Izquierdo LA, Tobey K & Curet LB (1998) Incidence of intraventricular hemorrhage in neonates under 32 weeks of gestation delivered to mothers with severe pre-eclampsia. Prenatal and Neonatal Medicine, 3, 250-254.
134. Martinez-Abundis E, Gonzalez-Ortiz M & Pascoe-Gonzalez S (2000) Serum leptin levels and the severity of preeclampsia. Arch Gynecol Obstet, 264, 71-73.
135. Maseki M, Nishigaki I, Hagihara M, Tomoda Y & Yagi K (1981a) Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subject with or without pre-eclampsia. Clin Chim Acta, 115, 115-161.
136. Maseki M, Nishigaki I, Hagihara M, Tomoda Y & Yagi K (1981b) Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without preeclampsia. Clinica Chimica Acta, 115, 155-161.
137. Mastrogiannis DS, O'Brien WF, Krammer J & Benoit R (1991) Potential role of endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol, 165, 1711-1716.
138. McCarthy AL, Woolfson RG, Raju SK & Poston L (1993) Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol, 168, 1323-1330.
139. McCarthy JF, Misra DN & Roberts JM (1999) Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol, 180, 731-736.
140. McCartney CP (1969) The acute hypertensive disorders of pregnancy, classified by renal histology. Gynaecologia, 167, 214-220.
141. Meis PJ, Goldenberg RL, Mercer BM, lams JD, Moawad AH, Miodovnik M, Menard MK, Caritis SN, Thurnau GR, Bottoms SF, Das A, Roberts JM & McNellis D (1998) The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Am J Obstet Gynecol, 178, 562-567.
142. Mills JL, DerSimonian R, Raymond E, Morrow JD, Roberts LJ, 2nd, Clemens JD, Hauth JC, Catalano P, Sibai B, Curet LB & Levine RJ (1999) Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA, 282, 356-362.
143. Minakami H, Takahashi T, Izumi A & Tamada T (1993) Increased levels of plasma thrombomodulin in preeclampsia. Gynecol Obstet Invest, 36, 208-210.
144. Mise H, Sagawa N, Matsumoto T, Yura S, Nanno H, Itoh H, Mori T, Masuzaki H, Hosoda K, Ogawa Y & Nakao K (1998) Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. J Clin Endocrinol Metab, 83, 3225-3229.
145. Mittendorf R, Lain KY, Williams MA & Walker CK (1996) Preeclampsia. A nested, case-control study of risk factors and their interactions. J Reprod Med, 41, 491-496.
146. Morgan L, Baker P, Pipkin FB & Kalsheker N (1995) Pre-eclampsia and the angiotensinogen gene. Br J Obstet Gynaecol, 102, 489-490.
147. Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL & Johnson AM (1995) Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet, 346, 1449-1454.
148. Murphy RP, Donoghue C, Nallen RJ, D'Mello M, Regan C, Whitehead AS & Fitzgerald DJ (2000) Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arteriosclerosis Thrombosis and Vascular Biology, 20, 266-270.
149. Musci TJ, Roberts JM, Rodgers GM & Taylor RN (1988) Mitogenic activity is increased in the sera of preeclamptic women before delivery. Am J Obstet Gynecol, 159, 1446-1451.
150. Nelson KB (1996) Magnesium sulfate and risk of cerebral palsy in very low-birth-weight infants [editorial; comment]. Journal of the American Medical Association, 276, 1843-1844.
151. Nelson KB & Grether JK (1995) Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics, 95, 263-269.
152. Ness RB & Roberts JM (1996) Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. [Review]. Am J Obstet Gynecol, 175, 1365-1370.
153. Nisell H & Hjemdahl P (1998) Pre-eclampsia-a state of sympathetic over-activity. Br J Obstet Gynaecol, 105, 931-932.
154. Nova A, Sibai BM, Barton JR, Mercer BM & Mitchell MD (1991) Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol, 165, 724-727.
155. Oshea TM, Klinepeter KL & Dillard RG (1998) Prenatal events and the risk of cerebral palsy in very low birth weight infants. Am J Epidemiol, 147, 362-369.
156. Oshea TM, Kothadia JM, Roberts DD & Dillard RG (1998) Perinatal Events and the Risk Of Intraparenchymal Echodensity In Very-Low-Birthweight Neonates. Paediatric & Perinatal Epidemiology, 12, 408-421.
157. Page EW (1939) The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol, 37, 291-293.
158. Palluy O, Morliere L, Gris JC, Boone C & Modat G (1992) Hypoxia/reoxygenation stimulates endothelium to promote neutrophil adhesion. Free Radic Biol Med, 13, 21-30.
159. Pascoal I, Lindheimer M, Nalbaltian-Brandt C & Umans J (1998) Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest, 101, 464-470.
160. Petri M (1998) Pregnancy In SLE [Review]. Baillieres Clin Rheumatol, 12, 449-476.
161. Pijnenborg R (1996) The placental bed. Hypertension in Pregnancy, 15, 7-23.
162. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L & van Assche A (1991) Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol, 98, 648-655.
163. Pijnenborg R, Robertson WB, Brosens I & Dixon G (1981) Review Article: Trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta, 2, 71-92.
164. Powers RW, Evens RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR & Roberts JM (1998) Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol, 179, 1605-1611.
165. Powers RW, Minich LA, Lykins DL, Ness RB, Crombleholme WR & Roberts JM (1999) Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J Soc Gynecol Investig, 6, 74-79.
166. Rajakumar A, Whitelock KA, Weissfeld LA, Daftary AR, Markovic N & Conrad KP (2001) Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia. Biol Reprod, 64, 499-506.
167. Rajkovic A, Catalano PM & Malinow MR (1997) Elevated homocyst(e)ine levels with preeclampsia. Obstet Gynecol, 90, 168-171.
168. Rauramo I & Forss M (1988) Effect of exercise on placental blood flow in pregnancies complicated by hypertension, diabetes or intrahepatic cholestasis. Acta Obstet Gynecol Scand, 67, 15-20.
169. Redman CW, Bonnar J & Beilin L (1978) Early platelet consumption in pre-eclampsia. Br Med J, 1, 467-469.
170. Redman CWG, Denson KWE & Beilin LJ (1977) Factor-VIII consumption in preeclampsia. Lancet, 2, 1249.
171. Reister F, Frank HG, Heyl W, Kosanke G, Huppertz B, Schroder W, Kaufmann P & Rath W (1999) The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta, 20, 229-233.
172. Roberts JM (1995) Preeclampsia: not simply pregnancy-induced hypertension. [Review]. Hosp Pract, 30, 25-28.
173. Roberts JM (1998a) Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol, 16, 5-15.
174. Roberts JM (1998b) Pregnancy related hypertension. In Maternal Fetal Medicine (Eds) Creasy RK & Resnik R, pp. 833-872. Philadelphia: W. B. Saunders.
175. Roberts JM, Edep ME, Goldfien A & Taylor RN (1992) Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence. Am J Reprod Immunol, 27, 101-108.
176. Roberts JM & Hubel CA (1999) Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet, 354, 788-789.
177. Roberts JM & Redman CWG (1993) Pre-eclampsia: More than pregnancy-induced hypertension. Lancet, 341, 1447-1451.
178. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA & McLaughlin MK (1989) Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol, 161, 1200-1204.
179. Robertson WB, Brosens IA & Dixon HG (1973) Placental bed vessels. Am J Obstet Gynecol, 117, 294-295.
180. Robillard P-Y & Hulsey TC (1996) Association of pregnancy-induced hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception. Lancet, 347, 619.
181. Robillard PY, Dekker GA & Hulsey TC (1998) Primipaternities in families-is the incidence of pregnancy-induced hypertensive disorders in multigravidas an anthropological marker of reproduction [Review]. Aust NZJ Obstet Gynaecol, 38, 284-287.
182. Rodgers GM, Taylor RN & Roberts JM (1988) Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells [see comments]. Am J Obstet Gynecol, 159, 908-914.
183. Rotmensch S, Liberati M, Mittelmann M & BenRafael Z (1997) Activated protein C resistance and adverse pregnancy outcome. Am J Obstet Gynecol, 177, 170-173.
184. Rudge MVC, Calderon IMP, Ramos MD, Peracoli JC & Pim A (1997) Hypertensive disorders in pregnant women wdth diabetes mellitus. Gynecol Obstet Invest, 44, 11-15.
185. Sacks GP, Studena K, Sargent IL & Redman CWG (1998) Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol, 179, 80-86.
186. Saitoh M, Usuki S, Murakami S & Kubo T (1996). Hyperhomocysteinemia: a risk factor for preclampsia. In 10th World Congress of the International Society for the Study of Hypertension in Pregnancy, pp. 96.
187. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA & Packard CJ (1997a) Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol, 89, 403-408.
188. Sattar N, Greer IA, Louden J, Lindsay G, McConnell M, Shepherd J & Packard CJ (1997b) Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab, 82, 2483-2491.
189. Schiff E, Ben-Baruch G, Peleg E, Rosenthal T, Alcalay M, Devir M & Mashiach S (1992) Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol, 166, 624-628.
190. Schobel HP, Fischer T, Heuszer K, Geiger H & Schmieder RE (1996) Preeclampsia-a state of sympathetic overactivity. N Engl J Med, 335, 1480-1485.
191. Schobel HP & Grassi G (1998) Hypertensive disorders of pregnancy-a dysregulation of the sympathetic nervous system. J Hypertens, 16, 569-570.
192. Schubring C, Kiess W, Englaro P, Rascher W, Dotsch J, Hanitsch S, Attanasio A & Blum WF (1997) Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endocrinol Metab, 82, 1480-1483.
193. Segrest JP & Anantharamaiah GM (1994) Pathogenesis of atherosclerosis. Curr Opin Cardiol, 9, 404-410.
194. Senaris R, Garcia-Caballero T, Casabiell X, Gallego R, Castro R, Considine RV, Dieguez C & Casanueva FF (1997) Synthesis of leptin in human placenta. Endocrinology, 138, 4501-4504.
195. Shembrey MA & Noble AD (1995) An instructive case of abdominal pregnancy. Aust NZJ Obstet Gynaecol, 35, 220-221.
196. Sibai B, El-Nazer A & Gonzalez-Ruiz A (1986) Severe preeclampsia-eclampsia in young primigravid women: Subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol, 155, 1011-1016.
197. Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, Goldenberg RL & Joffe G (1997) Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group [see comments]. Am J Obstet Gynecol, 177, 1003-1010.
198. Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D & Paul RH (1995) Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol, 172, 642-648.
199. Sikorski J (1998) Pre-eclampsia-a state of sympathetic over-activity. British Journal of Obstetrics and Gynaecology, 105, 126-127.
200. Sladek SM, Kanbour-Shakir A, Watkins S, Berghorn KA, Hoffman GE & Roberts JM (1998) Granulated metrial gland cells contain nitric oxide synthases during pregnancy in the rat. Placenta, 19, 55-65.
201. Smarason AK, Sargent IL, Starkey PM & Redman CWG (1993) The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. British Journal of Obstetrics and Gynaecology, 100, 943-949.
202. Smith GN, Walker M, Tessier JL & Millar KG (1997) Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility. Am J Obstet Gynecol, 177, 455-458.
203. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H & Kubo T (1997) Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet, 34, 525-526.
204. Steinberg D (1995) Role of oxidized LDL and antioxidants in atherosclerosis. Advances in Experimental Medicine & Biology, 369, 39-48.
205. Stone J, Lockwood C, Berkowitz G, Alvarez M, Lapinski R & Berkowitz R (1994) Risk factors for severe preeclampsia. Obstet Gynecol, 83, 357-361.
206. Talledo OE, Chesley L & Zuspan FP (1968) Renin-angiotensin system in normal and toxemic pregnancies. Am J Obstet Gynecol, 100, 218-221.
207. Taylor RN (1997) Review: Immunobiology of preeclampsia. Am J Reprod Immunol, 37, 79-86.
208. Taylor RN, Crombleholme WR, Friedman SA, Jones LA, Casal DC & Roberts JM (1991a) High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol, 165, 895-901.
209. Taylor RN, Heilbron DC & Roberts JM (1991) Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy. Am J Obstet Gynecol, 163, 1839-1844.
210. Taylor RN, Musci TJ, Kuhn RW & Roberts JM (1990a) Partial characterization of a novel growth factor from the blood of women with preeclampsia. Journal of Clinical Endocrinology & Metabolism, 70, 1285-1291.
211. Taylor RN, Musci TJ, Rodgers GM & Roberts JM (1991b) Preeclamptic sera stimulate increased platelet-derived growth factor mRNA and protein expression by cultured human endothelial cells. Am J Reprod Immunol, 25, 105-108.
212. Taylor RN, Varma M, Teng NNH & Roberts JM (1990b) Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. Journal of Clinical Endocrinology Metabolism, 71, 1675-1677.
213. Teppa RJ, Ness RB, Crombleholme WR & Roberts JM (2000) Free leptin is increased in normal pregnancy and further increased in preeclampsia. Metabolism-Clinical and Experimental, 49, 1043-1048.
214. Thorp J, White G, Moake J & W B (1990) von Willebrand factor multimeric levels and patterns in patients with severe preeclampsia. Obstet Gynecol, 75, 163-167.
215. Trupin LS, Simon LP & Eskenazi B (1996) Change in paternity: A risk factor for preeclampsia in multiparas. Epidemiology, 7, 240-244.
216. Tsukimori K, Maeda H, Shingu M, Koyanagi T, Nobunaga M & Nakano H (1993) Possible mechanism of vascular damage in pre-eclampsia. J Hum Hypertens, 8, 177-180.
217. Uotila J, Solakivi T, Jaakkola O, Tuimala R & Lehtimaki T (1998) Antibodies against copper-oxidised and malondialdehyde-modified low density lipoproteins in pre-eclamptic pregnancies. British Journal of Obstetrics and Gynaecology, 105, 1113-1117.
218. Uotila JT, Kirkkola AL, Rorarius M, Tuimala RJ & Metsa-Ketela T (1994) The total peroxyl radical-trapping ability of plasma and cerebrospinal fluid in normal and preeclamptic parturients. Free Radic Biol Med, 16, 581-590.
219. Walker JJ, Cameron AD, Bjornsson S, Singer CRJ & Fraser C (1989) Can platelet volume predict progressive hypertensive disease in pregnancy? Am J Obstet Gynecol, 161, 676-679.
220. Wallenburg HCS, Dekker GA, Makovitz JW & Rotmans N (1991) Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women. Am J Obstet Gynecol, 164, 1169-1173.
221. Walsh SW (1989) Low-Dose Aspirin: Treatment For The Imbalance of Increased Thromboxane and Decreased Prostacyclin in Preeclampsia. Am J Perinatol, 6, 124-132.
222. Wang Y, Walsh SW & Kay HH (1992) Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol, 167, 945-949.
223. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton RP & Lalouel JM (1993) A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet, 4, 59-61.
224. Wellings RP, Brockelsby JC & Baker PN (1998) Activation of endothelial cells by plasma from women with preeclampsia: differential effects on four endothelial cell types. J Soc Gynecol Investig, 5, 31-37.
225. Wlody DJ (1992) Hypertension in pregnancy. Nerv England Journal of Medicine, 327, 732.
226. Xiong X, Demianczuk NN, Buekens P & Saunders LD (2000) Association of preeclampsia with high birth weight for gestational age. Am J Obstet Gynecol, 183, 148-155.
227. Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH & Kim IO (1997) Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol, 177, 19-26.
228. Yura S, Sagawa N, Mise H, Mori T, Masuzaki H, Ogawa Y & Nakao K (1998) A positive umbilical venous-arterial difference of leptin level and its rapid decline after birth. Am J Obstet Gynecol, 178, 926-930.
229. Zhou Y, Damsky CH, Chiu K, Roberts JM & Fisher SJ (1993a) Cytotrophoblast expression of integrin extracellular matrix receptors is altered in preeclampsia. New York: Springer-Verlag, pp. 109-122.
230. Zhou Y, Damsky CH, Chiu K, Roberts JM & Fisher SJ (1993b) Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest, 91, 950-960.
231. Zhou Y, Damsky CH & Fisher SJ (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype-One cause of defective endovascular invasion in this syndrome? J Clin Invest, 99, 2152-2164.
232. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M & Damsky CH (1997) Human cytotrophoblasts adopt a vascular phenotype as they diiferentiate. A strategy for successful endovascular invasion? J Clin Invest, 99, 2139-2151.
233. Zhou Y, Genbacev O, Damsky CH & Fisher SJ (1998) Oxygen regulates human cytotrophoblast diiferentiation and invasion-implications for endovascular invasion in normal pregnancy and in pre-eclampsia. J Reprod Immunol, 39, 197-213.